Circulating endothelial cells (CECs) and progenitor cells are currently evaluated as potential biomarkers of antiangiogenic therapy. CD146 is considered a panendothelial-specific marker, but its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results